UK guidelines on PEP after sexual exposure (March 2006)
7 March 2006. Related: Guidelines.
2006
New US prescription drug information format to improve safety
6 March 2006. Related: Other news.
2nd International workshop on HIV and Hepatitis coinfection
6 March 2006. Related: On the web.
Medscape training resources
5 March 2006. Related: On the web.
HIV InSite Knowledge Base
5 March 2006. Related: On the web.
Top 10 research publications in HIV care in 2005
5 March 2006. Related: On the web.
Cardiovascular risk factors and metabolic complications in HIV-positive patients receiving HAART
5 March 2006. Related: On the web.
Report on dispersal of asylum seekers in the UK
4 March 2006. Related: On the web.
UK surveillance report
4 March 2006. Related: On the web.
GMHC: Treatment Issues
3 March 2006. Related: On the web.
FCHR roundtable report on CCR5 inhibitors
3 March 2006. Related: On the web.
IAVI report: 2005 year in review
3 March 2006. Related: On the web.
WHO – HIV/AIDS in Europe: moving from death sentence to chronic disease management
3 March 2006. Related: On the web.
Full text journal publications online
2 March 2006. Related: On the web.
Volume 7 Number 3 March 2006 PDF
1 March 2006. Related: PDFs.
Volume 7 Number 1/2 January/February 2006
26 February 2006. Related: Editorial.
10th European AIDS Conference (EACS), 17-20 November 2005, Dublin, Ireland
11 February 2006. Related: Conference reports.
Rifaximin cure reported for cryptosporidium in advanced HIV
11 February 2006. Related: Conference reports, Coinfections and complications.
Analysis of hepatic events in 2NN study by CD4 entry criteria, levels differences between nevirapine and efavirenz; excess hepatic events in once-daily nevirapine arm linked to single site in Thailand
11 February 2006. Related: Conference reports, Side effects.
FTC studies at EACS: reduced incidence of M184V compared to 3TC; side effect profile in clinical practice
11 February 2006. Related: Conference reports, Antiretrovirals.
Paediatric studies at EACS: trends in antiretroviral use in the Madrid Cohort; life expectancy significantly increased HIV/HCV co-infected children since HAART; use of tenofovir in treatment experienced children; switching to lopinavir/r from double protease inhibitor regimen; once daily lopinavir/r, 3TC and abacavir; planned treatment interruptions in children
11 February 2006. Related: Conference reports, Paediatric care.
Efficacy of lopinavir/r in patients with advanced HIV (CD4 <25 cells/mm3)
11 February 2006. Related: Conference reports, Antiretrovirals.
Potential barriers to use of T-20: results from patient and physician interviews
11 February 2006. Related: Conference reports, Antiretrovirals.
Factors associated with sexual dysfunction in HIV patients
11 February 2006. Related: Conference reports, Side effects.
Decreased varicella zoster immunity in migrants from sub-Saharan Africa
11 February 2006. Related: Conference reports, Coinfections and complications.
Clinical experience of switching to atazanavir in the UKs largest clinic
11 February 2006. Related: Conference reports, Antiretrovirals.
Replacing a PI with atazanavir: separating swans from ducklings?
11 February 2006. Related: Conference reports, Antiretrovirals.
TMC 125: some good and bad news
11 February 2006. Related: Conference reports, Antiretrovirals.
When to change a failing regimen: second-line and salvage strategies
11 February 2006. Related: Conference reports, Antiretrovirals.
Antiretrovirals and other stuff!
11 February 2006. Related: Conference reports, Antiretrovirals.
Heart disease in people with HIV
11 February 2006. Related: Conference reports.
Mortality trends: why people with HIV die (or dont) today
11 February 2006. Related: Conference reports.
45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
10 February 2006. Related: Conference reports.
Understanding TMC114 power against resistant HIV
10 February 2006. Related: Conference reports, Antiretrovirals.
New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients
10 February 2006. Related: Conference reports, Antiretrovirals.
Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
10 February 2006. Related: Conference reports, Paediatric care.
African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
10 February 2006. Related: Conference reports, Side effects.
Predictors of insulin resistance in first year of therapy
10 February 2006. Related: Conference reports, Side effects.
Three measures confirm 144-week renal record of tenofovir
10 February 2006. Related: Conference reports, Antiretrovirals.
Low rash risk with efavirenz after nevirapine rash
10 February 2006. Related: Conference reports, Antiretrovirals.
SMART study halted due to safety concerns with significantly more AIDS events in the treatment interruption arm
9 February 2006. Related: Antiretrovirals.
TMC114 (darunavir) new drug applications submitted to US and European regulatory agencies
9 February 2006. Related: Antiretrovirals.
Missing the target: a report on HIV/AIDS treatment access from the frontlines
9 February 2006. Related: Treatment access.
New Clinton agreements to lower prices of HIV/AIDS rapid tests and second-line drugs in 50 countries
9 February 2006. Related: Treatment access.
WHO adds seven antiretrovirals to list of prequalified HIV drugs
9 February 2006. Related: Treatment access.
Ranbaxy launches two new ARVs in India
9 February 2006. Related: Treatment access.
FDA tentative approvals: generic oral solutions of nevirapine and d4T
9 February 2006. Related: Treatment access.
Amendment to WTO TRIPS agreement makes access to affordable medicines even more bleak: MSF expresses concern that patients the world-over will have to pay the price
9 February 2006. Related: Treatment access.
WTO uses AIDS patients to cover up development round failure
9 February 2006. Related: Treatment access.
US paediatric guidelines updated (Feb 2006)
8 February 2006. Related: Paediatric care, Guidelines.
Low HIV viral load linked to hepatitis B vaccination response
8 February 2006. Related: Hepatitis coinfection.
HPA releases HCV report without mentioning sexual transmission among HIV-positive gay men
8 February 2006. Related: Hepatitis coinfection.
Jamaican HIV/AIDS advocate Steve Harvey murdered at age 30
7 February 2006. Related: Other news.
Serono labs pleads guilty to the illegal marketing of rHGH: company to pay $704 million global settlement
7 February 2006. Related: Other news.
Commission presents blueprint to fight HIV/AIDS over the 2006-2009 period
7 February 2006. Related: Other news.
Drug companies earn back R&D costs in short term and in developed countries
7 February 2006. Related: Other news.
Reports from CCR5 Antagonist meeting
6 February 2006. Related: On the web.
Online medical resources
6 February 2006. Related: On the web.
Volume 7 Number 1/2 January/February 2006 PDF
1 February 2006. Related: PDFs.